Unleashing the biotech potential in health

Applications of biotech in healthcare range from personalised medicines to biomarker testing which looks for genes, proteins, and other substances that can provide information about cancer. [SHUTTERSTOCK/ROMIXIMAGE]

Thanks to biotechnology applications such as PCR tests and mRNA vaccines, Europe saw a way out of the COVID-19 pandemic. What comes next is exploring the full potential of life science in the healthcare sector.

Vaccines based on mRNA technology have been successfully developed up to their commercial approval for the first time during the pandemic, together with the spread of monoclonal antibodies to even treat the effects of the diseases.

In this series of articles, EURACTIV reviews the forthcoming policy initiatives that will test the promising potential of biotech in the health sector also looking at some practical examples in the EU countries.

Subscribe to our newsletters

Subscribe